WHO: Corona Plasma an Experimental

Coronavirus plasma treatment still experimental, cautions WHO

The World Health Organization has cautioned that using blood plasma from COVID-19 survivors to treat other patients is still considered an experimental therapy. The United Nations agency today that preliminary study results are inconclusive and more rigorous research is underway. Yesterday, the US Food and Drug Administration authorized what’s called emergency use of the treatment under its special powers to speed the availability of promising experimental drugs.

WHO’s Chief Scientist Dr Soumya Swaminathan during a press briefing said that so far, the results are not conclusive. At the moment, it is still very low-quality evidence.

Convalescent plasma is a century-old treatment that was used to fight off flu and measles outbreaks in the days before vaccines, and was tried more recently during the Ebola outbreak.

Dr Swaminathan said, WHO considered plasma therapy to be experimental and that it should continue to be evaluated. She said the treatment is difficult to standardize: Plasma must be collected individually and people produce different levels of antibodies.

Published by Naresh Sagar

Mentor MSME, Motivator, Media Event Org, Management fiscal & Water management.Social Media branding,Internet broadcasters,Propunder of Indian Philosophy

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: